Inhibition of platelet function with bencyclane
Bédi, J.; Pálos, A.L.
Therapia Hungarica 24(2): 50-55
1976
ISSN/ISBN: 0133-3909 PMID: 982339 Document Number: 101545
Document emailed within 1 workday
Related Documents
Fiedel, B.A.; Simpson, R.M.; Gewurz, H. 1977: Effects of C-reactive protein on platelet function. III. the role of cAMP, contractile elements, and prostaglandin metabolism in CRP-induced inhibition of platelet aggregation and secretion Journal of Immunology 119(3): 877-882Nenci, G.G.; Berrettini, M.; Iadevaia, V.; Parise, P.; Ballatori, E. 1982: Inhibition of spontaneous platelet aggregation and adhesion by indobufen (K 3920). a randomized, double-blind crossover study on platelet, coagulation and fibrinolysis function tests Pharmatherapeutica 3(3): 188-194
Meyers, K.M.; Lindner, C.; Katz, J.; Grant, B. 1979: Phenylbutazone inhibition of equine platelet function American Journal of Veterinary Research 40(2): 265-270
Joist, J.H. 1970: Drug inhibition of blood platelet function. A new trend in the prevention of thromboembolic diseases Die Medizinische Welt 27: 1247-1251
Iioka, H.; Hisanaga, H.; Moriyama, I.; Akasaki, M.; Nabuchi, K.; Katakami, Y.; Katoh, Y.; Ichijo, M. 1989: The study on the platelet aggregation inhibition activity of placental brush border (the mechanism of platelet aggregation inhibition) Nihon Sanka Fujinka Gakkai Zasshi 41(12): 1916-1920
Yasunaga, K. 1979: Inhibition of platelet aggregation by platelet inhibitory agents and its relation to their clinical effects Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 40: 181-187
Müller, T.H.; Weisenberger, H.; Brickl, R.; Narjes, H.; Himmelsbach, F.; Krause, J. 1997: Profound and sustained inhibition of platelet aggregation by Fradafiban, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, and its orally active prodrug, Lefradafiban, in men Circulation 96(4): 1130-1138
Pniejnia-Olszyński, W.; Michalski, R. 1977: Blood platelet disorders. II. Acquired thrombocytopathies and action of drugs on platelet function Acta Haematologica Polonica 8(2): 151-156
Hitzler, W.; Vamvakas, E.C. 2011: Platelet microRNA Profiles and the Effect of Pathogen Reduction on Platelet Function Clinical Laboratory 57(7-8): 451-454
Klein, A.; Adamik, A.; Mischke, R. 1999: Changes in platelet concentrates from dogs due to storage. I. Platelet count in in vitro function Berliner und Munchener Tierarztliche Wochenschrift 112(6-7): 243-253
Suvatte, V.; Mahasandana, C.; Tanphaichitr, V.; Tuchinda, S. 1979: Acquired platelet dysfunction with eosinophilia: study of platelet function in 62 cases Southeast Asian Journal of Tropical Medicine and Public Health 10(3): 358-367
Heinrich, D.; Scharf, T.; Santoso, S.; Clemetson, K.J.; Mueller-Eckhardt, C. 1985: Monoclonal antibodies against human platelet membrane glycoproteins IIb-IIIa. II. Different effects on platelet function Thrombosis Research 38(5): 547-559
Zhang, X.X. 1985: A preliminary observation on changes of the platelet cyclic nucleotides and platelet function in coronary heart disease Zhonghua Xin Xue Guan Bing Za Zhi 13(3): 168-171
Higashihara, M.; Maeda, H.; Ohashi, T.; Oka, H.; Kume, S. 1987: The effect of a monoclonal antibody specific for human platelet GPIIb/IIIa (TP80) on platelet function Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 50(4): 926-935
Ketterl, R.; Haas, S.; Fritsche, H.M.; Lechner, F.; Blümel, G. 1980: Changes in platelet morphology and platelet function in the course of total hip endoprosthesis operations Die Medizinische Welt 31(20): 743-746
Escolar, G.; Cases, A.; Viñas, M.; Pino, M.; Calls, J.; Cirera, I.; Ordinas, A. 1999: Evaluation of acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyzer (PFA-100 ): influence of hematocrit elevation Haematologica 84(7): 614-619
Mak, K.H.; Kottke-Marchant, K.; Brooks, L.M.; Topol, E.J. 1998: In vitro efficacy of platelet glycoprotein IIb/IIIa antagonist in blocking platelet function in plasma of patients with heparin-induced thrombocytopenia Thrombosis and Haemostasis 80(6): 989-993
Rao, A.K.; Ghosh, S.; Sun, L.; Yang, X.; Disa, J.; Pickens, P.; Polansky, M. 1995: Mechanisms of platelet dysfunction and response to DDAVP in patients with congenital platelet function defects. a double-blind placebo-controlled trial Thrombosis and Haemostasis 74(4): 1071-1078
Hwang, S.B.; Li, C.L.; Lam, M.H.; Shen, T.Y. 1985: Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist Laboratory Investigation; a Journal of Technical Methods and Pathology 52(6): 617-630
Ho, J.L.; Kim, H.K.; Sass, P.M.; He, S.; Geng, J.; Xu, H.; Zhu, B.; Turco, S.J.; Lo, S.K. 1996: Structure-function analysis of Leishmania lipophosphoglycan. Distinct domains that mediate binding and inhibition of endothelial cell function Journal of Immunology 157(7): 3013-3020